Literature DB >> 7687121

Bleomycin affects cell wall anchorage of mannoproteins in Saccharomyces cerevisiae.

R Beaudouin1, S T Lim, J A Steide, M Powell, J McKoy, A J Pramanik, E Johnson, C W Moore, P N Lipke.   

Abstract

Bleomycin induces strand breakage in DNA through disruption of glycosidic linkages. We investigated the ability of bleomycin to damage yeast cell walls, which are composed primarily of carbohydrate. Bleomycin treatment of intact yeast cells facilitated enzymatic conversion of yeasts to spheroplasts. Bleomycin treatment also altered anchorage of mannoproteins to the cell wall matrix in intact cells or isolated cell walls. Cell surface mannoproteins were labelled with 125I, and their solubilization was monitored. Seventeen hour treatments with bleomycin released some of the label directly into treatment supernatants and facilitated extraction of mannoproteins by dithiothreitol and lytic enzymes. Bleomycin treatments as short as 10 min caused changes in extraction of mannoproteins from intact cells. Specifically, cell wall anchorage of several mannoproteins was affected by the drug. There were drug-induced changes in extractability of mannoproteins with apparent molecular weights of 96,000, 80,000, 61,000, 41,000, 31,500, and 21,000 (determined after deglycosylation with endo-N-acetylglucosaminidase H). The similarity of results obtained in the presence and absence of cycloheximide, the appearance of cell wall effects after only 10 min of treatment, and the similarity of effects in intact cells and isolated cell walls are consistent with direct drug-induced damage and inconsistent with a mechanism dependent on expression of bleomycin-damaged genes or other intracellular mediators. The results are consistent with bleomycin-mediated increases in cell wall permeability through disruption of glycosidic cross-linking structures in the cell wall.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7687121      PMCID: PMC187951          DOI: 10.1128/AAC.37.6.1264

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Purification and properties of an enzyme, zymolyase, which lyses viable yeast cells.

Authors:  K Kitamura; Y Yamamoto
Journal:  Arch Biochem Biophys       Date:  1972-11       Impact factor: 4.013

2.  Invertase and disulphide bridges in the yeast wall.

Authors:  D K Kidby; R Davies
Journal:  J Gen Microbiol       Date:  1970-06

3.  Gel protein stains: glycoproteins.

Authors:  J E Gander
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

4.  Order of events in the yeast secretory pathway.

Authors:  P Novick; S Ferro; R Schekman
Journal:  Cell       Date:  1981-08       Impact factor: 41.582

5.  Purification and properties of an endo-beta-N-acetylglucosaminidase from Streptomyces griseus.

Authors:  A L Tarentino; F Maley
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

6.  Effects of inositol starvation on phospholipid and glycan syntheses in Saccharomyces cerevisiae.

Authors:  B A Hanson; R L Lester
Journal:  J Bacteriol       Date:  1980-04       Impact factor: 3.490

7.  Lesions and preferential initial localization of [S-methyl-3H]bleomycin A2 on Saccharomyces cerevisiae cell walls and membranes.

Authors:  C W Moore; R Del Valle; J McKoy; A Pramanik; R E Gordon
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

8.  Modulation of bleomycin cytotoxicity.

Authors:  C W Moore
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

9.  Phosphomannanase (PR-factor), an enzyme required for the formation of yeast protoplasts.

Authors:  W L McLellan; J O Lampen
Journal:  J Bacteriol       Date:  1968-03       Impact factor: 3.490

10.  Saccharomyces cerevisiae mannoproteins form an external cell wall layer that determines wall porosity.

Authors:  H Zlotnik; M P Fernandez; B Bowers; E Cabib
Journal:  J Bacteriol       Date:  1984-09       Impact factor: 3.490

View more
  8 in total

1.  The regulatory factor X protein MoRfx1 is required for development and pathogenicity in the rice blast fungus Magnaporthe oryzae.

Authors:  Dandan Sun; Huijuan Cao; Yongkai Shi; Pengyun Huang; Bo Dong; Xiaohong Liu; Fucheng Lin; Jianping Lu
Journal:  Mol Plant Pathol       Date:  2016-09-20       Impact factor: 5.663

2.  Disruption of the Saccharomyces cerevisiae cell-wall pathway gene SLG1 causes hypersensitivity to the antitumor drug bleomycin.

Authors:  A Leduc; C H He; D Ramotar
Journal:  Mol Genet Genomics       Date:  2003-02-12       Impact factor: 3.291

3.  Bleomycin therapy of experimental disseminated candidiasis in mice.

Authors:  J R Graybill; R Bocanegra; A Fothergill; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

4.  Fungal cell wall septation and cytokinesis are inhibited by bleomycins.

Authors:  Carol W Moore; Judith McKoy; Robert Del Valle; Donald Armstrong; Edward M Bernard; Norman Katz; Ronald E Gordon
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

5.  Oxidative cell wall damage mediated by bleomycin-Fe(II) in Saccharomyces cerevisiae.

Authors:  S T Lim; C K Jue; C W Moore; P N Lipke
Journal:  J Bacteriol       Date:  1995-06       Impact factor: 3.490

6.  BacA-mediated bleomycin sensitivity in Sinorhizobium meliloti is independent of the unusual lipid A modification.

Authors:  Gail P Ferguson; An Jansen; Victoria L Marlow; Graham C Walker
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

7.  Nucleosome Assembly Protein 1, Nap1, Is Required for the Growth, Development, and Pathogenicity of Magnaporthe oryzae.

Authors:  Qing Wang; Jing Wang; Pengyun Huang; Zhicheng Huang; Yan Li; Xiaohong Liu; Fucheng Lin; Jianping Lu
Journal:  Int J Mol Sci       Date:  2022-07-11       Impact factor: 6.208

8.  Loss of a 20S proteasome activator in Saccharomyces cerevisiae downregulates genes important for genomic integrity, increases DNA damage, and selectively sensitizes cells to agents with diverse mechanisms of action.

Authors:  Kevin M Doherty; Leah D Pride; James Lukose; Brian E Snydsman; Ronald Charles; Ajay Pramanik; Eric G Muller; David Botstein; Carol Wood Moore
Journal:  G3 (Bethesda)       Date:  2012-08-01       Impact factor: 3.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.